July 14, 2026 09:01 ET | Source: Ernexa Therapeutics Inc. CEO discusses ERNA-101's potential to transform immunologically "cold" tumors into…
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Dandy, the fully digital dental lab, today unveiled Polychromatic Shade™, a category-defining…
ESTERO, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- Visory Health, one of the most used prescription discount cards, has won…
Cosmos Health will supply DIABIT-IS X (sitagliptin), while Libytec handles distribution and promotion in GreeceFive-year agreement expected to contribute to…
July 13, 2026 11:08 ET | Source: Zelluna ASA First patient dosed with ZI-MA4-1 in the ZIMA-101 Phase 1 trial…
Company announcement No. 32 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 28, 2026) Copenhagen, Denmark,…
New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients…
The new data demonstrates the potential to improve control of acute infection, latency, and viral reactivation, further supporting the concept…
July 12, 2026 06:28 ET | Source: Hemab Therapeutics, Inc. HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater…
Founded by two former enterprise executives, SoliVana combines 16 evidence-aligned therapies across 9 private rooms to address the stress and…